Use of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies.
The vaccination of wild animals against rabies has been developed most extensively in Europe. Experiments have demonstrated the efficacy of a vaccinia-rabies recombinant virus administered by the oral route in foxes. The innocuity of this vaccine was tested in the target species as well as in several non-target wild and domestic species. Because of its safety and heat-stability, this recombinant virus should offer an excellent alternative to the attenuated strains of rabies virus currently used in the field. A large scale field trial was conducted in Belgium in October 1988 to assess the efficacy of this new vaccine-bait systems.
Brochier
B
B
Department of Virology, Faculty of Veterinary Medicine, University of Liege, Brussels, Belgium.
Thomas
I
I
Bauduin
B
B
Leveau
T
T
Pastoret
P P
PP
Languet
B
B
Chappuis
G
G
Desmettre
P
P
Blancou
J
J
Artois
M
M
D000818:Animals; D002415:Cats; D005589:Foxes; D009115:Muridae / Q000276:immunology; D011818:Rabies / Q000517:prevention & control / Q000662:veterinary*; D011819:Rabies Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D011820:Rabies virus / Q000276:immunology; D013696:Temperature; D014611:Vaccination / Q000662:veterinary*; D014612:Vaccines / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology*; D014615:Vaccinia / Q000235:genetics / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology*
D011819:Rabies Vaccines; D014612:Vaccines; D014614:Vaccines, Synthetic; D014765:Viral Vaccines